期刊文献+

2型糖尿病神经病变患者血清Hcy水平表达及其临床意义研究 被引量:1

Study on Serum Hcy Expression and Its Clinical Significance in Type 2 Diabetic Neuropathy Patients
下载PDF
导出
摘要 目的分析2型糖尿病(T2DM)神经病变患者血清同型半胱氨酸(Hcy)水平表达及其临床意义。方法选取90例T2DM神经病变患者作为观察组,另选取同期收治的60例T2DM患者作为对照组,比较两组血清Hcy水平、生化指标及血糖,并分析危险因素。结果观察组HDL-C水平低于对照组,HbA1c、Hcy水平高于对照组(P<0.05);Logistic显示,病程、HDL-C、HbA1c及Hcy水平是糖尿病患者并发神经病变的独立危险因素(P<0.05)。结论病程越长、HDL-C水平降低、H bA1c和Hcy水平升高是T2DM患者神经病变发生的主要危险因素。 Objective To analyze the expression of serum homocysteine(Hcy)and its clinical significance in patients with neuropathy in type 2 diabetes mellitus(T2DM).Methods 90 patients with T2DM neuropathy were selected as the observation group,and 60 patients with T2DM admitted in the same period were selected as the control group.Serum Hcy level,biochemical indexes and blood glucose were compared between the two groups,and risk factors were analyzed.Results The levels of HDL-C and HbA1c and Hcy in the observation group were lower than those in the control group(P<0.05).Logistic showed that the course of disease,HDL-C,HbA1c and Hcy levels were independent risk factors for neuropathy in diabetic patients(P<0.05).Conclusion The longer course of disease,the lower HDL-C level,and the higher HbAlc and Hcy levels are the main risk factors for neuropathy in T2DM patients.
作者 张云 许玉丹 蒋志健 ZHANG Yun;XU Yu-dan;JIANG Zhi-jian(Clinical Laboratory,Nanyang Hospital of Traditional Chinese Medicine,Nanyang 473000,Henan Province,China)
出处 《罕少疾病杂志》 2021年第6期91-92,共2页 Journal of Rare and Uncommon Diseases
关键词 2型糖尿病 神经病变 血清Hcy水平 Type 2 Diabetes Neuropathy Serum Hcy Levels
  • 相关文献

参考文献7

二级参考文献77

  • 1李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:211
  • 2相爱霞,陈成华,董砚虎.糖尿病神经病变研究进展[J].国外医学(内分泌学分册),2004,24(6):424-425. 被引量:9
  • 3王宏利,樊东升,洪天配,高洪伟.血清同型半胱氨酸水平与2型糖尿病周围神经病变的关系[J].中国糖尿病杂志,2007,15(5):299-302. 被引量:23
  • 4Dellon AL, Aszmann OA, Tassler P. Outcome of surgical decompression of nerves in diabetic on incidence of ulceration and amputation [J]. J Reconstr Micro, 2003, 19:350-355.
  • 5World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication: Part 1: report of a WHO consultation: diagnosis and classification of diabetes mellitus [ Z ]. Geneva: World Health Org, 1999.
  • 6Edwards JL, Vincent AM, Cheng HL, et al. Diabetic neuropathy: mechanisms to management [ J ]. Pharmacol Ther, 2008, 120 (1) : 1 -34.
  • 7Jensen TS, Bach FW, Kastrup J, et al. Vibratory and thermal thresholds in diabetics with and without clinical neuropathy [ J ]. Aeta Neurol Seand, 1991, 84 (4): 326-333.
  • 8Kitano Y, Kuwabara-S, Misawa S, et al. The acute effects of glycemic control on axonal excitability in human diabetics [ J]. Ann Neuril, 2004, 56 (4): 462-467.
  • 9Li G, Sun C, Wang Y, et al. A clinical and neuropathological study of Chinese patients with diabetic peripheral neuropathy [ J ]. PLoS One, 2014, 9 (3): e91772.
  • 10Owolabi MO, Ipadeola A, Adeleye JO. Aggregate cardiovascular riskis a stronger statistical correlate of clinically evident diabetic peripheral neuropathy than HbAlc alone [ J ]. J Natl Med Assoc, 2010, 102 (8): 707-712.

共引文献374

同被引文献14

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部